^

Health

Yves ker

, medical expert
Last reviewed: 23.04.2024
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Eve care is a combination drug for women that provides effective treatment in cases where there is dysmenorrhea or premenstrual syndrome.

Indications Yves ker

Indications for use of ivecker suggest its use to treat the following menstrual disorders in adult women.

The drug is effective for countering the negative phenomena arising in connection with a complex complex of regularly appearing symptoms in the time interval from 2 to 10 days preceding menstruation. This drug helps to minimize the violations of vegetative, metabolic-endocrine and psychoemotional state of women with premenstrual syndrome.

The number of indications, in which the use of the drug is justified, includes various types of abnormal anomalies in the process of menstruation. Among them, first of all, it is necessary to note dysmenorrhea. Dysmenorrhea is characterized by the fact that blood clots come out with menstrual blood, which is accompanied by quite strong pain symptoms.

Further, in cases in which there may be a reasonableness of the use of IVC, there are violations of the monthly cycle, which characterizes menorrhagia. This condition has its manifestations of bleeding in the uterus, which occurs with a certain regularity and is characterized by a long duration - more than 7 days. In this case, there is a significant loss of blood.

The drug is also indicated when metrorrhagia acts as a violation of the normal functioning of the female reproductive system. She is characterized by the appearance of acyclic bleeding, not related to the normal monthly cycle.

The next indication for IVBC is an oligomenorrhea, characterized by an abnormally rare onset of menstruation, occurring at a frequency less than once in 40 days. There are some cases in which menstruation occurred only once in six months.

Thus, indications for the use of IVC can be justified both in the case of irregularities in the cyclicity and duration of menstruation, and in cases of dysfunctional uterine bleeding during periods between them, and in addition for other dysfunctions associated with the menstrual cycle in women of childbearing age.

Release form

So, let's consider what is the form of the release of Yves Cur. The drug is offered by the manufacturer, and this is the Indian company HIMALAYA DRUG CO., In the form of capsules. Capsules of lilac color, from hard gelatin. Under their shell are granules and powder in color from brown to gray-brown hue. The following active ingredients of plant origin are included in each capsule.

In the form of extracts:

  • Ashoka - 85 mg
  • Dashmoula - 35 mg
  • simplocos racemose - 35 mg
  • tinospora heart-shaped - 35 mg
  • nightshade black - 35 mg
  • Punarnava 35 mg
  • asparagus, racemose - 35 mg
  • aloe - 25 mg
  • to feed round - 25 mg
  • Santal white - 25 mg
  • adhatod vasika - 20 mg
  • Bombax Malabar - 15 mg,
  • triphal - 20 mg
  • Tricate 20 mg.

Powders:

  • cacis déanti basma - 35 mg
  • zinc basma - 20 mg

Pharmacodynamics

Pharmacodynamics Ivker manifests itself in a synergistic pharmacological action as a set of such actions rendered individually by the components of the preparation.

As a result of taking the drug, the content of estrogens in the blood serum increases, regulation of the secretory processes of hormones of endogenous origin improves. Providing a stimulating effect in relation to ovarian tissue, the use of the drug leads to activation of hormonal secretion functions, promotes the restoration of endometriotic regeneration, acts as a regulator of the intensity of uterine bleeding.

The action produced by Ivesker in the body consists in bringing the hormonal balance to an optimum, in normalizing the cycles of menstruation and in controlling the amount of blood loss. The drug has properties that provide favorable conditions for restoring the endometrium. The use of ivecker is able to act as a factor in the effective normalization of the cycle in cases of uterine bleeding of a dysfunctional nature. In addition, the effect of the drug is expressed in a decrease in the intensity of pathogenic phenomena during the onset of menopause. Ivker also participates in immunomodulating processes and helps to increase hemoglobin levels in the blood.

Summarizing the above, we note that the pharmacodynamics of Ivker has a beneficial, purposeful effect on the physiological side of the problem of menstrual cycle disorders, providing for the removal of inflammation and producing an analgesic analgesic effect, and in addition it has a stabilizing effect on the psychic and emotional spheres of a woman when premenstrual syndrome occurs.

trusted-source[1], [2]

Pharmacokinetics

Concerning such an inherent characteristic of the preparation as the pharmacokinetics of Ivesker, to say that either it is not possible to determine anything at the present time. The reason for this lies in the fact that this issue is not sufficiently studied and comprehensively examined.

trusted-source[3], [4]

Dosing and administration

Dosing and Administration Ivker suggests taking the drug orally twice per day in the amount of one or two capsules once.

The duration of the treatment course is 3 months.

trusted-source[9], [10], [11]

Use Yves ker during pregnancy

The use of IVC ker during pregnancy belongs to the list of contraindications existing for the rules and principles of the use of this drug.

It is also recommended to refrain from taking Yves Kher by a woman during the entire time period in which her infant is breastfed.

Contraindications

Contraindications to the use of IVC ker are mainly reduced to the refusal to use the drug for women with hypersensitivity or individual intolerance, whatever it was, from the components that make up it.

Another prohibitive factor is the fact that Ivker is exclusively for women and the use by men is unacceptable.

The drug is also classified as unsuitable for prescription because of childhood.

It is necessary to exclude Iv Kehr from the list of drugs offered for treatment for the entire period of bearing a pregnant woman and the subsequent period of breastfeeding.

trusted-source[5]

Side effects Yves ker

Side effects of IVC Cure are manifested in the fact that taking the drug in some cases can be accompanied by the occurrence of allergies of varying severity.

The strength of the allergic reaction of the organism to its active substances is dependent on the degree of possible individual intolerance of some of their number and their totality.

trusted-source[6], [7], [8]

Overdose

Overdose of IVC ker in none of the cases of treatment with the use of this drug was not noted.

trusted-source[12], [13]

Interactions with other drugs

Interactions of IVC with other drugs have not been studied.

trusted-source[14], [15]

Storage conditions

Ivker's storage conditions require that the preparation be kept in a location with an extremely low level of humidity.

The temperature regime necessary for Yves Kehr to maintain its therapeutic pharmacological properties throughout the manufacturer's declared shelf life should correspond to a range of 10 to 30 degrees Celsius.

Another important factor in the preservation of the drug is, as far as possible, to isolate it as far as possible from light.

trusted-source[16], [17], [18], [19]

Special instructions

A distinctive feature of it in comparison with the whole multitude of various drugs of analgesic and spasmolytic action, as well as with various hormonal preparations, is that its composition includes exclusively plant components. Due to this circumstance, the likelihood of any side effects arising from the use of the drug is minimal.

Active antispasmodic and anti-inflammatory properties make it useful in the treatment of diseases of the reproductive system of women. The drug has a stimulating effect on the uterus, which as a result contributes to the ordering and normalization of the menstrual cycle. Stimulation of ovarian tissues provides optimization of the processes of hormone-secretory function, which ensures an increase in the ability to restore the endometrium of the uterus. This, in turn, is a positive factor that prevents the occurrence of excessively intensive uterine bleeding.

In addition, when using the drug, its immunomodulating effect is actualized, and it also has a favorable effect on the level of hemoglobin in the blood. Proceeding from the above set of specific features of IvCer, it can be argued that it is such a drug that protects women's health, which on the one hand has effective therapeutic properties in menstrual cycle disorders, ensuring its normalization, and on the other serves as a general restorative for significant bleeding caused by abnormal bleeding in the uterus, and is also effective for relieving the associated painful sensations.

Shelf life

Shelf life - 3 years.

trusted-source

Attention!

To simplify the perception of information, this instruction for use of the drug "Yves ker" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.

Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.

Translation Disclaimer: For the convenience of users of the iLive portal this article has been translated into the current language, but has not yet been verified by a native speaker who has the necessary qualifications for this. In this regard, we warn you that the translation of this article may be incorrect, may contain lexical, syntactic and grammatical errors.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.